ClinicalTrials.gg
Drug

Diacerein clinical trials

Also written CCP-020, Artrodar and AC-201.

studies test it
37
open now
3
in phase 3
6
first study started
1993

How each study uses diacerein is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study

Get an email when these change. Save the diacerein studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Get alerts for these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your alerts, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your alerts. Stop any time.

Approvals

The first approval found in each region, with its record

United States
Not in FDA's approval records
European Union
Not in EMA's list of EU-wide authorizations

From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out

How studies write it

Studies that test it under each name

Name

Diacerein
16
diacerein 1% ointment
7
Diacerein 50 mg Capsule
3

Brand

Artrodar
4

Development codes

CCP-020
7
AC-201
3
AC-203
2

Other names

Diacetylrhein
1
Diacerhein
1

Studies by the year they started

36 studies that test it; most in 2018 (6)

Studies that test diacerein, by start year
YearStudies
19931
20051
20072
20081
20101
20111
20135
20143
20161
20174
20186
20191
20202
20221
20244
20251
20261

By phase

A phase 1/2 study counts in both.

Phase 1
6
Phase 2
17
Phase 3
6
Phase 4
9
No phase
1

What it is tested for

Each study’s main condition, where its own words name it, so a study counts once.

Who runs them

Industry 21 · Other 16

Castle Creek Pharmaceuticals, LLC (7) · TWi Biotechnology, Inc. (6) · Laboratoires NEGMA (3) · TRB Chemedica (2) · University of Campinas, Brazil (2) · Accro Bioscience (Suzhou) Limited (1) · Universitas Sriwijaya (1) · TRB Chemedica International SA (1)

Often tested with

Tested in the same studies.

Eltrombopag (2) · Glucosamine (1) · Chondroitin (1) · Celecoxib (1)

Coming up

From the study records. Dates are the sponsors’ own estimates and often move.

Reaching primary completion within a year · 2, 1 in phase 3

Studies that test diacerein, phase 3 first.

Studies

Open first, then newest update. How each study uses diacerein is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.

Testing it · 37

See all 37 studies that test diacerein →

What changed recently

From the registry's own updates since Oct 18, 2026.

Started recruiting1

Codes

What other systems call diacerein · ClinicalTrials.gg INT002809

  • MeSH (NLM) C025292diacereinConfirmed ClinicalTrials.gov, NLM, Wikidata
  • UNII (FDA) 4HU6J11EL5DIACEREINConfirmed FDA, NLM, Wikidata
  • RxNorm 22759Confirmed FDA, Wikidata
  • Wikidata Q413178diacereinConfirmed FDA, NLM, Wikidata
  • NCI Thesaurus C166759DiacereinOne source FDA
  • DrugBank DB11994One source Wikidata

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.